trimetazidine has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Harmat, M; Janszky, J; Juhász, A; Kovács, N; Pintér, D | 1 |
| Harmat, M; Janszky, J; Juhász, A; Kovács, M; Kovács, N; Pintér, D | 1 |
| Arslan, Ş; Baş, YC; Üreyen, ÇM | 1 |
3 other study(ies) available for trimetazidine and Parkinson Disease
| Article | Year |
|---|---|
The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Female; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Trimetazidine | 2020 |
Trimetazidine and parkinsonism: A prospective study.
Topics: Aged; Antiparkinson Agents; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Prospective Studies; Tremor; Trimetazidine | 2019 |
Primum non nocere.
Topics: Aged, 80 and over; Beneficence; Female; Humans; Muscle Rigidity; Parkinson Disease; Trimetazidine | 2015 |